{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:29:13Z","timestamp":1789615753745,"version":"build-2803163510"},"reference-count":176,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The lymphatic vascular system spans nearly every organ in the body and serves as an important network that maintains fluid, metabolite, and immune cell homeostasis. Recently, there has been a growing interest in the role of lymphatic biology in chronic disorders outside the realm of lymphatic abnormalities, lymphedema, or oncology, such as cardiovascular-kidney-metabolic syndrome (CKM). We propose that enhancing lymphatic function pharmacologically may be a novel and effective way to improve quality of life in patients with CKM syndrome by engaging multiple pathologies at once throughout the body. Several promising therapeutic targets that enhance lymphatic function have already been reported and may have clinical benefit. However, much remains unclear of the discreet ways the lymphatic vasculature interacts with CKM pathogenesis, and translation of these therapeutic targets to clinical development is challenging. Thus, the field must improve characterization of lymphatic function in preclinical mouse models of CKM syndrome to better understand molecular mechanisms of disease and uncover effective therapies.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1412857","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:00:41Z","timestamp":1718125241000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities"],"prefix":"10.3389","volume":"11","author":[{"given":"Joseph Wayne M.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LouJin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Roth Flach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21(st) century: novel functional roles in homeostasis and disease","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-023-01723-x","article-title":"Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/lrb.2008.1008","article-title":"The lymphatic system in health and disease","volume":"6","author":"Cueni","year":"2008","journal-title":"Lymphat Res Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/cvr\/cvw175","article-title":"Heterogeneity in the lymphatic vascular system and its origin","volume":"111","author":"Ulvmar","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"597374","DOI":"10.3389\/fcvm.2020.597374","article-title":"Ras pathways on Prox1 and lymphangiogenesis: insights for therapeutics","volume":"7","author":"Bui","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/gb-2005-6-2-209","article-title":"The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease","volume":"6","author":"Holmes","year":"2005","journal-title":"Genome Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1083\/jcb.144.4.789","article-title":"LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan","volume":"144","author":"Banerji","year":"1999","journal-title":"J Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nri1670","article-title":"Dendritic-cell trafficking to lymph nodes through lymphatic vessels","volume":"5","author":"Randolph","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jacc.2022.10.028","article-title":"Albuminuria and heart failure: JACC state-of-the-art review","volume":"81","author":"Khan","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00828-y","article-title":"A new era in the science and care of kidney diseases","author":"Zoccali","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41581-021-00438-y","article-title":"The lymphatics in kidney health and disease","volume":"17","author":"Donnan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fphys.2019.01402","article-title":"The lymphatic system in obesity, insulin resistance, and cardiovascular diseases","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Physiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1161\/ATVBAHA.120.314735","article-title":"Lymphatics in cardiovascular disease","volume":"40","author":"Zhou","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/ajh\/hpx085","article-title":"Current trends of hypertension treatment in the United States","volume":"30","author":"Shah","year":"2017","journal-title":"Am J Hypertens"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1152\/physrev.00037.2011","article-title":"Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer","volume":"92","author":"Wiig","year":"2012","journal-title":"Physiol Rev"},{"key":"B20","article-title":"Congestive heart failure and pulmonary edema","volume-title":"StatPearls","author":"King","year":"2024"},{"key":"B21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ejhf.321","article-title":"Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review","volume":"17","author":"Platz","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-020-0798-y","article-title":"Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities","volume":"115","author":"Cuijpers","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.jacc.2020.10.022","article-title":"Reduced lymphatic reserve in heart failure with preserved ejection fraction","volume":"76","author":"Rossitto","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.115.020143","article-title":"Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction","volume":"133","author":"Henri","year":"2016","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature14483","article-title":"Cardiac lymphatics are heterogeneous in origin and respond to injury","volume":"522","author":"Klotz","year":"2015","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/cvr\/cvac086","article-title":"Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure","volume":"119","author":"Heron","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1002\/ctm2.374","article-title":"VEGF-C\/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis","volume":"11","author":"Lin","year":"2021","journal-title":"Clin Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jacbts.2023.01.008","article-title":"Cardiac lymphatic insufficiency leads to diastolic dysfunction via myocardial morphologic change","volume":"8","author":"Pu","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physrev.00052.2021","article-title":"The ebb and flow of cardiac lymphatics: a tidal wave of new discoveries","volume":"103","author":"Harris","year":"2023","journal-title":"Physiol Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1074\/jbc.273.12.6599","article-title":"A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities","volume":"273","author":"Joukov","year":"1998","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.humpath.2005.01.001","article-title":"Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries","volume":"36","author":"Nakano","year":"2005","journal-title":"Hum Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc2697","article-title":"Efficient aortic lymphatic drainage is necessary for atherosclerosis regression induced by ezetimibe","volume":"6","author":"Yeo","year":"2020","journal-title":"Sci Adv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1172\/JCI63685","article-title":"Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice","volume":"123","author":"Martel","year":"2013","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2019.01.031","article-title":"Early rescue of lymphatic function limits atherosclerosis progression in ldlr(-\/-) mice","volume":"283","author":"Milasan","year":"2019","journal-title":"Atherosclerosis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/ATVBAHA.114.302528","article-title":"Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis","volume":"34","author":"Vuorio","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fphar.2015.00182","article-title":"The role of the lymphatic system in cholesterol transport","volume":"6","author":"Huang","year":"2015","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1172\/JCI71610","article-title":"Lymphatic transport of high-density lipoproteins and chylomicrons","volume":"124","author":"Randolph","year":"2014","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fphys.2019.00251","article-title":"Renal lymphatics: anatomy, physiology, and clinical implications","volume":"10","author":"Russell","year":"2019","journal-title":"Front Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/labinvest.2017.77","article-title":"Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction","volume":"97","author":"Hasegawa","year":"2017","journal-title":"Lab Invest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1267\/ahc.13006","article-title":"Altered dynamics in the renal lymphatic circulation of type 1 and type 2 diabetic mice","volume":"46","author":"Uchiyama","year":"2013","journal-title":"Acta Histochem Cytochem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41374-019-0259-0","article-title":"Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease","volume":"99","author":"Zarjou","year":"2019","journal-title":"Lab Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ekir.2021.12.029","article-title":"The density of renal lymphatics correlates with clinical outcomes in IgA nephropathy","volume":"7","author":"Rodas","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41419-020-03385-x","article-title":"Lymphangiogenesis in renal fibrosis arises from macrophages via VEGF-C\/VEGFR3-dependent autophagy and polarization","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48183","article-title":"Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease","volume":"8","author":"Jafree","year":"2019","journal-title":"Elife"},{"key":"B46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/HJH.0000000000002349","article-title":"Kidney-specific lymphangiogenesis increases sodium excretion and lowers blood pressure in mice","volume":"38","author":"Balasubbramanian","year":"2020","journal-title":"J Hypertens"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010084","article-title":"A kidney-targeted nanoparticle to augment renal lymphatic density decreases blood pressure in hypertensive mice","volume":"14","author":"Goodlett","year":"2021","journal-title":"Pharmaceutics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.312765","article-title":"Enhancing renal lymphatic expansion prevents hypertension in mice","volume":"122","author":"Lopez Gelston","year":"2018","journal-title":"Circ Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85096","article-title":"Restoration of lymphatic function rescues obesity in Prox1-haploinsufficient mice","volume":"1","author":"Escobedo","year":"2016","journal-title":"JCI Insight"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ng1642","article-title":"Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity","volume":"37","author":"Harvey","year":"2005","journal-title":"Nat Genet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1097\/GOX.0000000000000398","article-title":"Obesity-induced lymphedema nonreversible following massive weight loss","volume":"3","author":"Greene","year":"2015","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"B52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1089\/wound.2020.1337","article-title":"Current overview of obesity-induced lymphedema","volume":"11","author":"Sudduth","year":"2022","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1038\/s41467-021-23808-3","article-title":"Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells","volume":"12","author":"Cifarelli","year":"2021","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"155268","DOI":"10.1016\/j.phymed.2023.155268","article-title":"Berberine promotes lacteal junction zippering and ameliorates diet-induced obesity through the RhoA\/ROCK signaling pathway","volume":"124","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aap9331","article-title":"Lacteal junction zippering protects against diet-induced obesity","volume":"361","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3389\/fphys.2019.01579","article-title":"Emerging roles for lymphatics in chronic liver disease","volume":"10","author":"Burchill","year":"2019","journal-title":"Front Physiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cmet.2017.07.020","article-title":"The lymphatic vasculature: its role in adipose metabolism and obesity","volume":"26","author":"Escobedo","year":"2017","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fphys.2020.00404","article-title":"The role of lymphatic vascular function in metabolic disorders","volume":"11","author":"Norden","year":"2020","journal-title":"Front Physiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-021-00309-7","article-title":"Primary lymphoedema","volume":"7","author":"Brouillard","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","article-title":"Lymphatic malformations: genetics, mechanisms and therapeutic strategies","volume":"129","author":"Makinen","year":"2021","journal-title":"Circ Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1196\/annals.1413.008","article-title":"Molecular regulation of lymphatic contractility","volume":"1131","author":"Muthuchamy","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.biocel.2003.12.008","article-title":"Lymphatic smooth muscle: the motor unit of lymph drainage","volume":"36","author":"von der Weid","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-4939-8712-2_15","article-title":"Methods for assessing the contractile function of mouse lymphatic vessels ex vivo","volume":"1846","author":"Castorena-Gonzalez","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"745096","DOI":"10.3389\/fphys.2021.745096","article-title":"Ex vivo demonstration of functional deficiencies in popliteal lymphatic vessels from TNF-transgenic mice with inflammatory arthritis","volume":"12","author":"Scallan","year":"2021","journal-title":"Front Physiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1113\/jphysiol.2012.250662","article-title":"Genetic removal of basal nitric oxide enhances contractile activity in isolated murine collecting lymphatic vessels","volume":"591","author":"Scallan","year":"2013","journal-title":"J Physiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI71612","article-title":"Emerging lymphatic imaging technologies for mouse and man","volume":"124","author":"Sevick-Muraca","year":"2014","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.addr.2020.08.013","article-title":"Imaging technology of the lymphatic system","volume":"170","author":"Polomska","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41586-019-1419-5","article-title":"Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid","volume":"572","author":"Ahn","year":"2019","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e201700017","DOI":"10.1002\/jbio.201700017","article-title":"Simultaneous measurements of lymphatic vessel contraction, flow and valve dynamics in multiple lymphangions using optical coherence tomography","volume":"11","author":"Blatter","year":"2018","journal-title":"J Biophotonics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/eji.202048879","article-title":"Non invasive in vivo monitoring of dimethyl fumarate treatment in EAE by assessing the glucose metabolism in secondary lymphoid organs","volume":"51","author":"Bruck","year":"2021","journal-title":"Eur J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/RMR.0000000000000130","article-title":"MRI Of the central lymphatic system: indications, imaging technique, and pre-procedural planning","volume":"26","author":"Pamarthi","year":"2017","journal-title":"Top Magn Reson Imaging"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2528\/pier14032303","article-title":"Photoacoustic tomography: principles and advances","volume":"147","author":"Xia","year":"2014","journal-title":"Electromagn Waves (Camb)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"74e","DOI":"10.1097\/PRS.0b013e3182063639","article-title":"Use of indocyanine green fluorescent lymphography for evaluating dynamic lymphatic status","volume":"127","author":"Suami","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e90861","DOI":"10.1172\/jci.insight.90861","article-title":"Quantitative measurement of lymphatic function in mice by noninvasive near-infrared imaging of a peripheral vein","volume":"2","author":"Proulx","year":"2017","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e4326","DOI":"10.3791\/4326","article-title":"Non-invasive optical imaging of the lymphatic vasculature of a mouse","author":"Robinson","year":"2013","journal-title":"J Vis Exp"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.mayocp.2020.01.006","article-title":"Overview of lymphedema for physicians and other clinicians: a review of fundamental concepts","volume":"97","author":"Manrique","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2214\/AJR.21.27200","article-title":"Lymphatic anomalies in children: update on imaging diagnosis, genetics, and treatment","volume":"218","author":"Snyder","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/lrb.2015.0040","article-title":"Near-infrared fluorescence lymphatic imaging to reconsider occlusion pressure of superficial lymphatic collectors in upper extremities of healthy volunteers","volume":"14","author":"Belgrado","year":"2016","journal-title":"Lymphat Res Biol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1038\/s41598-019-46797-2","article-title":"A novel mouse tail lymphedema model for observing lymphatic pump failure during lymphedema development","volume":"9","author":"Weiler","year":"2019","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0092-8674(01)00449-4","article-title":"Dendritic cells: specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2353\/ajpath.2009.080963","article-title":"Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration","volume":"175","author":"Lim","year":"2009","journal-title":"Am J Pathol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e70703","DOI":"10.1371\/journal.pone.0070703","article-title":"Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes","volume":"8","author":"Weitman","year":"2013","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"19817","DOI":"10.1038\/srep19817","article-title":"Inhibition of inflammation and iNOS improves lymphatic function in obesity","volume":"6","author":"Torrisi","year":"2016","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.193.1.51","article-title":"Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes","volume":"193","author":"Vermaelen","year":"2001","journal-title":"J Exp Med"},{"key":"B85","article-title":"Lymphedema","volume-title":"StatPearls","author":"Sleigh","year":"2024"},{"key":"B86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-019-0072-5","article-title":"Cancer-associated secondary lymphoedema","volume":"5","author":"Rockson","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B87","doi-asserted-by":"publisher","first-page":"12677","DOI":"10.1073\/pnas.221449198","article-title":"A model for gene therapy of human hereditary lymphedema","volume":"98","author":"Karkkainen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e31088","DOI":"10.1002\/micr.31088","article-title":"Surgical lymphedema models in the mice hindlimb-A systematic review and quality assessment","volume":"44","author":"Bucan","year":"2024","journal-title":"Microsurgery"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3791\/61848","article-title":"A murine tail lymphedema model","author":"Hassanein","year":"2021","journal-title":"J Vis Exp"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1002\/ctm2.758","article-title":"TGF-beta1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation","volume":"12","author":"Baik","year":"2022","journal-title":"Clin Transl Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1172\/JCI96063","article-title":"Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3791\/64576","article-title":"Popliteal vascular lymph node resection in the rabbit hindlimb for secondary lymphedema induction","author":"Campos","year":"2022","journal-title":"J Vis Exp"},{"key":"B93","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2019.00470","article-title":"Regulation of immune function by the lymphatic system in lymphedema","volume":"10","author":"Kataru","year":"2019","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s13239-022-00645-z","article-title":"Evaluation of longitudinal lymphatic function changes upon injury in the mouse tail with photodynamic therapy","volume":"14","author":"Kuzminich","year":"2023","journal-title":"Cardiovasc Eng Technol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072546","article-title":"Histopathologic features of lymphedema: a molecular review","volume":"21","author":"Li","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B96","first-page":"54","article-title":"Mouse tail models of secondary lymphedema: fibrosis gradually worsens and is irreversible","volume":"13","author":"Zhou","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1242\/dev.195453","article-title":"YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling","volume":"147","author":"Cha","year":"2020","journal-title":"Development"},{"key":"B98","doi-asserted-by":"publisher","first-page":"8389","DOI":"10.1038\/s41467-023-44133-x","article-title":"Molecular and metabolic orchestration of the lymphatic vasculature in physiology and pathology","volume":"14","author":"Montenegro-Navarro","year":"2023","journal-title":"Nat Commun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1101\/gad.216226.113","article-title":"The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors","volume":"28","author":"Srinivasan","year":"2014","journal-title":"Genes Dev"},{"key":"B100","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-08-1875","article-title":"Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype","volume":"69","author":"Issa","year":"2009","journal-title":"Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/TP.0000000000000561","article-title":"Vascular endothelial growth factor c\/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics","volume":"99","author":"Iwami","year":"2015","journal-title":"Transplantation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"eabg0809","DOI":"10.1126\/scitranslmed.abg0809","article-title":"Alpelisib administration reduced lymphatic malformations in a mouse model and in patients","volume":"13","author":"Delestre","year":"2021","journal-title":"Sci Transl Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1038\/s41467-020-16496-y","article-title":"Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation","volume":"11","author":"Martinez-Corral","year":"2020","journal-title":"Nat Commun"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s44161-022-00147-0","article-title":"Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition","volume":"1","author":"Sung","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34323","article-title":"VEGF-C promotes the development of lymphatics in bone and bone loss","volume":"7","author":"Hominick","year":"2018","journal-title":"Elife"},{"key":"B106","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/cvr\/cvp207","article-title":"Mouse strain determines the outcome of wound healing after myocardial infarction","volume":"84","author":"van den Borne","year":"2009","journal-title":"Cardiovasc Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/cvr\/cvx090","article-title":"Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice","volume":"113","author":"Villalba-Orero","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/JCI172844","article-title":"Lymphatic malformations: mechanistic insights and evolving therapeutic frontiers","volume":"134","author":"Petkova","year":"2024","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1086\/316915","article-title":"Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome","volume":"67","author":"Fang","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cge.13204","article-title":"Splice-site mutations in VEGFC cause loss of function and nonne-milroy-like primary lymphedema","volume":"94","author":"Fastre","year":"2018","journal-title":"Clin Genet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13221-016-0035-5","article-title":"A novel mutation in CELSR1 is associated with hereditary lymphedema","volume":"8","author":"Gonzalez-Garay","year":"2016","journal-title":"Vasc Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1086\/303019","article-title":"Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase","volume":"67","author":"Irrthum","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B113","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/scitranslmed.aax8013","article-title":"Characterization of ANGPT2 mutations associated with primary lymphedema","volume":"12","author":"Leppanen","year":"2020","journal-title":"Sci Transl Med"},{"key":"B114","first-page":"43","article-title":"The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema","volume":"44","author":"Szuba","year":"2003","journal-title":"J Nucl Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jvs.2010.04.067","article-title":"A novel method of measuring human lymphatic pumping using indocyanine green fluorescence lymphography","volume":"52","author":"Unno","year":"2010","journal-title":"J Vasc Surg"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e30419","DOI":"10.1002\/pbc.30419","article-title":"Pathogenic variants in PIK3CA are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly","author":"Grenier","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","article-title":"Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development","volume":"92","author":"Kaipainen","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B119","doi-asserted-by":"publisher","first-page":"40973","DOI":"10.1074\/jbc.M304499200","article-title":"Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites","volume":"278","author":"Dixelius","year":"2003","journal-title":"J Biol Chem"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1182\/blood-2005-04-1388","article-title":"Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways","volume":"106","author":"Salameh","year":"2005","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/emboj.2010.30","article-title":"VEGF Receptor 2\/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts","volume":"29","author":"Nilsson","year":"2010","journal-title":"EMBO J"},{"key":"B122","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1126\/science.282.5390.946","article-title":"Cardiovascular failure in mouse embryos deficient in VEGF receptor-3","volume":"282","author":"Dumont","year":"1998","journal-title":"Science"},{"key":"B123","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/humu.22223","article-title":"FLT4\/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update","volume":"34","author":"Gordon","year":"2013","journal-title":"Hum Mutat"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/ATVBAHA.120.314370","article-title":"Lymphatic and immune cell cross-talk regulates cardiac recovery after experimental myocardial infarction","volume":"40","author":"Houssari","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e009565","DOI":"10.1161\/JAHA.118.009565","article-title":"Impact of lymphangiogenesis on cardiac remodeling after ischemia and reperfusion injury","volume":"7","author":"Shimizu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1172\/JCI97192","article-title":"The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction","volume":"128","author":"Vieira","year":"2018","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147070","article-title":"Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction","volume":"131","author":"Keller","year":"2021","journal-title":"J Clin Invest"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.58376","article-title":"Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension","volume":"9","author":"Song","year":"2020","journal-title":"Elife"},{"key":"B129","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1681\/ASN.2014090856","article-title":"Vascular endothelial growth factor C for polycystic kidney diseases","volume":"27","author":"Huang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"F91","DOI":"10.1152\/ajprenal.00066.2022","article-title":"Formation of the glomerular microvasculature is regulated by VEGFR-3","volume":"324","author":"Donnan","year":"2023","journal-title":"Am J Physiol Renal Physiol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136970","article-title":"Lymphangiogenesis and lymphatic barrier dysfunction in renal fibrosis","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.bjps.2020.05.009","article-title":"Phase 1 lymfactin(\u00ae) study: short-term safety of combined adenoviral VEGF-C and lymph node transfer treatment for upper extremity lymphedema","volume":"73","author":"Hartiala","year":"2020","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B133","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/CIRCULATIONAHA.110.965384","article-title":"Growth factor therapy and autologous lymph node transfer in lymphedema","volume":"123","author":"Lahteenvuo","year":"2011","journal-title":"Circulation"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1016\/j.bjps.2022.08.011","article-title":"Phase 1 lymfactin(R) study: 24-month efficacy and safety results of combined adenoviral VEGF-C and lymph node transfer treatment for upper extremity lymphedema","volume":"75","author":"Leppapuska","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B135","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"B136","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCRESAHA.123.321673","article-title":"Clinical potential of adrenomedullin signaling in the cardiovascular system","volume":"132","author":"Balint","year":"2023","journal-title":"Circ Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/01.cir.101.5.498","article-title":"Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure","volume":"101","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"B139","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1160\/th07-02-0128","article-title":"Adrenomedullin and endothelial barrier function","volume":"98","author":"Temmesfeld-Wollbruck","year":"2007","journal-title":"Thromb Haemost"},{"key":"B140","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1172\/JCI33302","article-title":"Adrenomedullin signaling is necessary for murine lymphatic vascular development","volume":"118","author":"Fritz-Six","year":"2008","journal-title":"J Clin Invest"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/jid.2013.47","article-title":"Adrenomedullin haploinsufficiency predisposes to secondary lymphedema","volume":"133","author":"Nikitenko","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/cvr\/cvn228","article-title":"Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema","volume":"80","author":"Jin","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/CIRCRESAHA.118.313835","article-title":"Adrenomedullin induces cardiac lymphangiogenesis after myocardial infarction and regulates cardiac edema via connexin 43","volume":"124","author":"Trincot","year":"2019","journal-title":"Circ Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00134-007-0561-y","article-title":"Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock","volume":"33","author":"Temmesfeld-Wollbruck","year":"2007","journal-title":"Intensive Care Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/bcp.13655","article-title":"Safety, tolerability and pharmacokinetics\/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects","volume":"84","author":"Geven","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","article-title":"Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial","volume":"47","author":"Laterre","year":"2021","journal-title":"Intensive Care Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.peptides.2014.05.005","article-title":"Biological properties of adrenomedullin conjugated with polyethylene glycol","volume":"57","author":"Kubo","year":"2014","journal-title":"Peptides"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2174\/092986707780830943","article-title":"Adrenomedullin in the kidney-renal physiological and pathophysiological roles","volume":"14","author":"Nishikimi","year":"2007","journal-title":"Curr Med Chem"},{"key":"B149","first-page":"66","article-title":"Adrenomedullin in the kidney: physiology and pathophysiology","volume":"57","author":"Sogbe-Diaz","year":"2016","journal-title":"Invest Clin"},{"key":"B150","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.biopha.2018.10.040","article-title":"Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice","volume":"109","author":"Bech","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B151","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/oby.23012","article-title":"Adrenomedullin attenuates inflammation in white adipose tissue of obese rats through receptor-mediated PKA pathway","volume":"29","author":"Dai","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/42506","article-title":"A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis","volume":"387","author":"Yokomizo","year":"1997","journal-title":"Nature"},{"key":"B154","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1084\/jem.192.3.421","article-title":"A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders","volume":"192","author":"Yokomizo","year":"2000","journal-title":"J Exp Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","article-title":"Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation","volume":"49","author":"Shimizu","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3920","article-title":"Leukotriene B(4) antagonism ameliorates experimental lymphedema","volume":"9","author":"Tian","year":"2017","journal-title":"Sci Transl Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123775","article-title":"Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema","volume":"3","author":"Rockson","year":"2018","journal-title":"JCI Insight"},{"key":"B158","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/j.1875-9114.1986.tb03459.x","article-title":"Ketoprofen: a review of its pharmacologic and clinical properties","volume":"6","author":"Kantor","year":"1986","journal-title":"Pharmacotherapy"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s42255-021-00457-w","article-title":"Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity","volume":"3","author":"Cao","year":"2021","journal-title":"Nat Metab"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1073\/pnas.1714446115","article-title":"Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP","volume":"115","author":"Souma","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B161","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/jnci\/djs009","article-title":"Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis","volume":"104","author":"Holopainen","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"B162","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI155478","article-title":"Lymphangiogenesis requires Ang2\/tie\/PI3K signaling for VEGFR3 cell-surface expression","volume":"132","author":"Korhonen","year":"2022","journal-title":"J Clin Invest"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1101\/gad.237677.114","article-title":"Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions","volume":"28","author":"Zheng","year":"2014","journal-title":"Genes Dev"},{"key":"B164","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1172\/JCI71603","article-title":"Lymphangiogenic factors, mechanisms, and applications","volume":"124","author":"Zheng","year":"2014","journal-title":"J Clin Invest"},{"key":"B165","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tem.2023.03.004","article-title":"The physiological functions of lymphangiocrine signals","volume":"34","author":"Liu","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"B166","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41586-020-2998-x","article-title":"Lymphoangiocrine signals promote cardiac growth and repair","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1054\/bjoc.2000.1396","article-title":"Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues","volume":"83","author":"Akagi","year":"2000","journal-title":"Br J Cancer"},{"key":"B168","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cam4.51","article-title":"Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo","volume":"2","author":"Nouguerede","year":"2013","journal-title":"Cancer Med"},{"key":"B169","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.bjc.6603487","article-title":"The role of the VEGF-C\/VEGFR-3 axis in cancer progression","volume":"96","author":"Su","year":"2007","journal-title":"Br J Cancer"},{"key":"B170","doi-asserted-by":"publisher","first-page":"589218","DOI":"10.3389\/fonc.2020.589218","article-title":"Targeting adrenomedullin in oncology: a feasible strategy with potential as much more than an alternative anti-angiogenic therapy","volume":"10","author":"Vazquez","year":"2020","journal-title":"Front Oncol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"B172","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Shibuya","year":"2006","journal-title":"Exp Cell Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1161\/CIRCRESAHA.116.310477","article-title":"VEGFR3 modulates vascular permeability by controlling VEGF\/VEGFR2 signaling","volume":"120","author":"Heinolainen","year":"2017","journal-title":"Circ Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db18-0045","article-title":"VEGFC Reduces glomerular albumin permeability and protects against alterations in VEGF receptor expression in diabetic nephropathy","volume":"68","author":"Onions","year":"2019","journal-title":"Diabetes"},{"key":"B175","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-immunol-041015-055354","article-title":"The lymphatic system: integral roles in immunity","volume":"35","author":"Randolph","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/ATVBAHA.122.318406","article-title":"Promoting lymphangiogenesis and lymphatic growth and remodeling to treat cardiovascular and metabolic diseases","volume":"43","author":"Liu","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1412857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:00:48Z","timestamp":1718125248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1412857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":176,"alternative-id":["10.3389\/fcvm.2024.1412857"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1412857","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"article-number":"1412857"}}